XML 46 R22.htm IDEA: XBRL DOCUMENT v3.21.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)
6 Months Ended 12 Months Ended
Nov. 24, 2020
USD ($)
$ / shares
shares
Dec. 18, 2019
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
Subsidiary, Sale of Stock [Line Items]            
Sale of Private Placement Warrants (in shares) | shares       6,439 6,439  
Cash and Cash Equivalents, at Carrying Value       $ 18,808,458 $ 32,478,948 $ 27,787,314
LifeSci Acquisition II Corp            
Subsidiary, Sale of Stock [Line Items]            
Proceeds from sale of Private Placement Warrants       $ 2,831,809    
Transaction Costs $ 1,858,498          
Underwriting fees 1,601,808          
Other offering costs $ 256,690          
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account       80.00%    
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination       50.00%    
Cash and Cash Equivalents, at Carrying Value     $ 25,000 $ 416,111    
Cash of not held in the trust account and available for working capital purposes       416,111    
Aggregate purchase price     $ 25,000      
Proceeds from Related Party Debt       175,000    
Condition for future business combination number of businesses minimum   1        
Payments for investment of cash in Trust Account       80,090,412    
Working capital subject to annual limit       250,000    
Condition for future business combination threshold Net Tangible Assets       $ 5,000,001    
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent       20.00%    
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)       100.00%    
Threshold business days for redemption of public shares       5 days    
Initial Public Offering | LifeSci Acquisition II Corp            
Subsidiary, Sale of Stock [Line Items]            
Sale of Units, net of underwriting discounts and offering expenses (in shares) | shares 8,009,041          
Purchase price, per unit | $ / shares $ 10.00          
Payments for investment of cash in Trust Account $ 80,090,412          
Private Placement | Private Placement Warrants | LifeSci Acquisition II Corp            
Subsidiary, Sale of Stock [Line Items]            
Sale of Units, net of underwriting discounts and offering expenses (in shares) | shares       8,009,041    
Sale of Private Placement Warrants (in shares) | shares 3,146,454     3,146,454    
Price of warrant | $ / shares $ 0.90     $ 0.90    
Proceeds from sale of Private Placement Warrants $ 2,831,809     $ 2,831,809    
Over-allotment option | LifeSci Acquisition II Corp            
Subsidiary, Sale of Stock [Line Items]            
Sale of Units, net of underwriting discounts and offering expenses (in shares) | shares 509,041          
Purchase price, per unit | $ / shares $ 10.00     $ 10.00    
Proceeds from issuance initial public offering $ 80,090,412